Mucopurulent Rhinorrhea
Mucopurulent rhinorrhea (i.e., purulent nasal discharge) denotes nasal discharge that is thick, opaque, and colored.1 It occurs at any age and usually is a manifestation of a self-limited and uncomplicated viral upper respiratory tract infection (URI). Mucopurulent rhinorrhea is most problematic in children younger than 3 years because of a protracted course and frequent recurrence, especially in those in out-of-home childcare2; parental concern and misperception about the cause; and overprescription of antibiotics by healthcare providers.3, 4, 5 Occasionally, this symptom is a clue to the diagnosis of a treatable bacterial infection or underlying condition.
Acute, sporadic mucopurulent rhinorrhea has an infectious cause and almost always is the manifestation of a viral upper respiratory tract infection or the uncomplicated common cold due to rhinoviruses, coronaviruses, human metapneumovirus (MPV), influenza, enteroviruses, parainfluenza, respiratory syncytial virus (RSV), or other circulating viruses.6, 7 When the problem is chronic or recurrent or persistent and unilateral, broader underlying anatomic, obstructive, immunologic, and allergic disorders are considered (Table 21.1 ).8, 9, 10 Onset in an infant younger than 3 months heightens suspicion of an anatomic anomaly, ciliary dyskinesia, or cystic fibrosis. Accompanying sinusitis, otitis media, or pneumonia at this young age prompts consideration of an immunologic deficiency, especially humoral immunodeficiency (e.g., hypogammaglobulinemia, agammaglobulinemia, human immunodeficiency virus [HIV] infection); neutrophil defect; cystic fibrosis; or ciliary dyskinesia. URIs are conspicuously severe in such instances, with recrudescence occurring almost immediately after discontinuation of antibiotic therapy. Unilateral nasal discharge and obstruction should prompt investigation for a foreign body, mass lesion, or unilateral posterior choanal atresia.
TABLE 21.1.
Causes of Mucopurulent Rhinorrhea
| Acute | Chronic or Recurrent |
|
|---|---|---|
| Underlying Conditions | Obstructing Lesions | |
|
|
|
Rhinorrhea is characteristically clear, but an opaque, white discharge is not unusual.
Rhinorrhea is characteristically clear.
Table 21.2 shows differentiating features of important or common causes of acute mucopurulent rhinorrhea. Allergic rhinitis is included because of its place in the differential diagnosis for older children and adolescents.
TABLE 21.2.
Differentiating Among Causes of Nasal Discharge
| Characteristic | Viral Nasopharyngitis | Acute Bacterial Sinusitis | Streptococcal Nasopharyngitis | Foreign Body–Related Bacterial Rhinitis | Allergic Rhinitis |
|---|---|---|---|---|---|
| HISTORY | |||||
| Peak age | Peak in first 2 yr after enrollment in childcare or school | Any | <3 yr | <3 yr | >2 yr |
| Onset | Acute; dryness, burning in nose or nasopharynx | Insidious with cough day and night or with secondary fever or worsening upper respiratory tract infection symptoms; occasionally, acute, febrile, toxic | Insidious; occasionally acute, febrile, toxic | Insidious | Can be seasonal or perennial; precipitants often identified |
| Associated symptoms | Nasal congestion, sneezing, malaise | Malodorous breath; head or facial pain, edema | Malodorous breath ± hyponasal voice | Sneezing; nasal congestion, nasal itching; postnasal drip/cough, allergic conjunctivitis with itching and tearing | |
| Fever | Yes/no | No/yes | Low/high | No | No |
| Duration of discharge | 3–15 days | ≥10 days | >5 days | Chronic | Seasonal or perennial |
| PHYSICAL EXAMINATION | |||||
| Associated findings | Red, excoriated nares; sometimes acute otitis media | Periorbital swelling, facial tenderness; mucopurulent postnasal discharge | Anterior cervical lymphadenitis; impetiginous lesions below nose | Mouth-breathing | Transverse nasal or lower eyelid creases; infraorbital edema and darkening, conjunctivitis, cobblestoning of conjunctivae or posterior pharynx |
| Character of discharge | Clear or colored, watery or thick | Thick, colored | Thick, colored | Unilateral, purulent, putrid bloodstained | Watery, clear |
| Rhinoscopy | Hyperemic mucosa; dry or glazed early, edematous later; crusted discharge | Normal mucosa; discharge from middle meatus | Normal, hyperemic, or excoriated mucosa | Identifiable object (button, pit, nut), boggy mass (vegetable), or rhinolith | Pale or blue, edematous turbinates |
| DIAGNOSIS | |||||
| Diagnostic tests | None; nasal smear shows neutrophils and mononuclear cells ± inclusion bodies, pyknotic epithelial cells | None unless suppurative complications suspected | Nasopharyngeal culture for Streptococcus only | Rhinoscopy | Positive allergen skin tests or serum IgE levels, rhinoscopy or nasal smear in rare cases |
| ETIOLOGY | |||||
| Causes | Multiple agents, depending on age and season | Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis | Streptococcus pyogenes | Normal nasopharyngeal facultative and anaerobic bacteria | Allergens |
| TREATMENT | |||||
| Therapies | Saline nasal drops, humidification; antibiotic only for secondary bacterial infection (acute otitis media or sinusitis) | Amoxicillin; amoxicillin-clavulanate (14:1 formulation), 90 mg/kg/day of amoxicillin component | Penicillin V | Removal of obstruction; amoxicillin-clavulanate for tissue or sinus complication | Allergen avoidance; glucocorticoid nasal spray, oral antihistamines, antihistamine nasal sprays, leukotriene receptor antagonists, nasal saline irrigation, allergen immunotherapy |
Causes
Viral Nasopharyngitis
In uncomplicated viral nasopharyngitis or rhinitis, the nasal discharge initially is clear but can become white, yellow, or green due to mucous secretions, dryness, blood, exfoliation of damaged epithelial cells and cilia, and a leukocytic inflammatory response. High fever and persistence of discharge can be seen, depending on the specific viral agent, but they are more common in uncomplicated infection than generally perceived.
In a study of hospitalized children, more than 50% with uncomplicated adenovirus, influenza, parainfluenza, or RSV infection had temperatures greater than 39°C, and 12% had temperatures greater than 40°C; the height of fever in these children was not different from that in children with serious bacterial infection.11 Fever persisted for 5 or more days in 37% of the children in the study; 20% to 30% of those with adenovirus or influenza A infection had fever for ≥7 days. In another study, nasal discharge or congestion associated with uncomplicated URI persisted for 6.6 days in 1- to 2-year-old children who were in home care and for 8.9 days in children younger than 1 year in out-of-home childcare.1 In a systematic review of studies on the common cold and nonspecific URIs in children, symptoms resolved in 50% by day 10 and 7, respectively, and in 90% by days 15 and 16.12, 13
The bacteriology of nasopharyngeal flora in children with uncomplicated viral respiratory illnesses, mucopurulent rhinorrhea, acute otitis media, and sinusitis has been evaluated and compared with that in healthy children.6, 14, 15, 16, 17, 18, 19, 20, 21 Viral infection is associated with acquisition of new serotypes of Streptococcus pneumoniae and with temporally increased risk of acute otitis media.20 Quantitative and some qualitative differences in nasopharyngeal flora have been found in children with purulent nasopharyngitis during uncomplicated viral URIs, with excessive isolation rates reported for S. pneumoniae and Haemophilus influenzae, Peptostreptococcus spp., Fusobacterium spp., and Prevotella melaninogenica. 14, 18, 19 Differences may reflect new bacterial acquisition or exuberant proliferation in virus-induced inflammatory mucus or availability of a more robust specimen than in healthy subjects. A high rate (25%−46%) of isolation of S. pneumoniae does not exceed that in healthy young children when fastidious technique is used.21
In a prospective study, there was no difference in the duration of illness or complications in children with clear or purulent nasal discharge.15 A large Cochrane meta-analysis concluded no benefit of antibiotic therapy in children with URI or cough.5, 22 In a placebo-controlled, blinded study of 142 children 3 months to 3 years old with mucopurulent rhinorrhea of any duration, antibiotic therapy (e.g., cephalexin) or systemic use of an antihistamine-decongestant, or both, had no effect on the course or complications of mucopurulent rhinorrhea.14 In a meta-analysis of randomized, controlled trials assessing the effect of probiotics on URIs in children and adults, significantly fewer days of illness and absences from childcare, school, or work occurred in those receiving a probiotic (i.e., Lactobacillus or Bifidobacterium strains) compared with placebo.16
Acute bacterial adenoiditis has been postulated as a cause of purulent nasal discharge when tympanic membranes are normal, S. pyogenes is not found in culture specimens, and radiographs show an enlarged adenoid shadow but no sinus abnormality.23 No study has been performed to validate this entity. Mucopurulent rhinorrhea plus additional clinical features, such as prolonged or new fever, cough or ill appearance; stridor or auscultatory abnormalities can indicate another diagnosis.
Bacterial Sinusitis
Bacterial sinusitis reportedly complicates 5% to 10% of viral upper respiratory tract infections in children.24 In a prospective study of 236 children 4 to 7 years of age, 8.8% of symptomatic URIs were complicated by sinusitis using the definitions that follow; all episodes met one of the first two definitions.13 Mucopurulent rhinorrhea or daytime cough (which frequently is worse at night), or both, of 10 or more days′ duration without improvement, worsening symptoms (i.e., recrudescence after improvement or new onset of fever), or severe onset of symptoms with fever of 39°C or higher and purulent nasal discharge for at least 3 consecutive days strongly suggests paranasal bacterial sinusitis and response to antibiotic therapy.25, 26, 27
Guidelines on the diagnosis and management of acute bacterial rhinosinusitis have been published.24, 26, 27 Sinus radiographs show significant abnormalities in almost 90% of children 2 to 6 years old and many older children with uncomplicated upper respiratory tract illness, supporting a clinical approach to diagnosis without imaging.
Streptococcal Nasopharyngitis
In children younger than 3 years of age, S. pyogenes can be associated with high fever, toxicity, and rhinorrhea or indolent infection with irregular fever and purulent nasal discharge, sometimes with associated excoriation of nares or tender anterior cervical lymphadenitis.13, 18, 25 In a streptococcal outbreak studied in a childcare facility for school-aged and young children, 26% of children younger than 3 years of age were affected, but pharyngitis was predominant, with no case of nasal streptococcosis.28
Other Infectious Causes
Bacterial nasopharyngitis associated with a nasal foreign body is typified by the young age of the patient and putrid, commonly bloodstained, unilateral nasal discharge. Fever is unusual unless infection has spread to contiguous sinuses or distant sites. Prevotella, Fusobacterium, and Peptostreptococcus spp., as well as facultative flora, are responsible. Nasal discharge can be the first manifestation of congenital syphilis and a later finding in nasal diphtheria, in which discharge is putrid and sanguineous with pieces of pseudomembrane.
Allergic Rhinitis
Allergic rhinitis is uncommon before 2 years of age. Diagnosis can be suspected because of the season, environmental precipitants, personal and family history of allergy or atopy, other associated symptoms, physical findings, and the response to specific interventions, such as avoidance or pharmacotherapy (see Table 21.2). Nasal secretions typically are clear.
Management
For most children with purulent nasal discharge (even if thick and green) of up to 1 week's duration, the history and setting of illness, associated symptoms, and physical findings suggest an uncomplicated viral URI. Antimicrobial therapy is inappropriate unless acute otitis media or sinusitis is diagnosed from additional findings.5 Symptomatic therapy with saline nose drops or lavage facilitates expulsion of secretions and provides humidification. Its effectiveness reduces parental pressure to prescribe an antibiotic.29 Over-the-counter medications should be avoided for children, especially those younger than 6 years of age. Antipyretic or analgesic medication is appropriate for the treatment of fever and discomfort.
If mucopurulent rhinorrhea persists for more than 5 days, especially if the epidemiology or certain findings (e.g., anterior cervical lymphadenopathy, scarlatiniform rash, excoriation around nostrils) heighten the likelihood of streptococcal disease, nasopharyngeal specimens should be obtained for the culture of S. pyogenes only. If the culture is positive, penicillin V is given for 10 days. Routine culture for or recovery of S. pneumoniae, H. influenzae, Moraxella catarrhalis, or Staphylococcus aureus has no meaning and can result in misinterpretation.
If mucopurulent rhinorrhea persists for 10 or more days without diminution, especially if other symptoms are present, paranasal sinusitis is likely. Nasal mucosa is examined after use of a single or second (i.e., 5 minutes after the first) application of a topical vasoconstrictor such as oxymetazoline. If purulent secretions flow from the middle meatus, the diagnosis of acute sinusitis is confirmed. Signs of allergic rhinitis can also be confirmed. An imaging study such as contrast-enhanced computed tomography is performed if suppurative complication of sinusitis is suspected.26, 27
Patients fulfilling a definition of sinusitis are treated with a high-dose (90 mg/kg/day) of amoxicillin with or without clavulanate as first-line therapy, which has been shown to decrease the duration of symptoms.30 When antimicrobial therapy is effective, substantial improvement of symptoms is expected within 48 to 72 hours. Therapy is continued for 10 to 14 days in children and at least 1 week after resolution of symptoms.26
Stridor
Characteristics
Stridor is a rough, high-pitched, monophonic sound caused by passage of air through a narrowed upper airway, which includes the extrathoracic trachea, larynx, and hypopharynx. Because the extrathoracic airway normally narrows during the inspiratory phase of respiration, stridor due to upper-airway disease occurs during inspiration or is more pronounced during inspiration if severe narrowing causes obstruction during inspiration and expiration. Because the intrathoracic trachea normally narrows during expiration, obstruction of the intrathoracic trachea, as occurs with extrinsic compression from a vascular ring or sling or intraluminal obstruction from a foreign body, inflammation, or tracheomalacia, causes a loud noise that is acoustically like stridor and heard during both phases of respiration, but it is more pronounced on expiration. Extrathoracic obstruction (i.e., inspiratory stridor) is associated with prolonged inspiration and underaeration of the chest, whereas intrathoracic obstruction (i.e., expiratory stridor or wheezing) is associated with prolonged expiration and an overinflated chest.
Stridor can be associated with mild tachypnea, but a respiratory rate higher than 50 breaths/min should not be ascribed to upper airway obstruction alone. The degree of obstruction associated with stridor can range from minimal to life-threatening.31
The timbre of the stridulous sound provides a clue to the cause. For example, a high-pitched, fixed, dry sound is associated with congenital subglottic stenosis; a wet, rhonchal changing sound with inflammatory laryngotracheitis; and a low-pitched, vibratory, positionally variable sound with laryngomalacia. Associated voice changes also are useful in specifying disease. Vocal cord paralysis causes a weak, dysphonic cry, supraglottic obstruction causes a muffled voice, and laryngotracheitis causes hoarseness or aphonia, frequently with a barking cough.
Etiology
Categorization of the setting and duration of stridor as acute, persistent, or recurrent/episodic provides a framework for considering likely causes (Table 21.3 ).31, 32, 33, 34 Infections cause most acute upper airway obstruction by means of intraluminal, epithelial inflammation or by encroachment on the airway by reactive or infected lymphoid tissue in parapharyngeal or paratracheal spaces. Viral laryngotracheitis is the most common cause of abrupt-onset stridor in young children.31 Fungal or viral tracheobronchitis must be considered when stridor occurs in an immunocompromised child; odynophagia and dysphagia also are common.32
TABLE 21.3.
Causes of Upper-Airway Obstruction and Stridor
| Acute | Persistent |
|---|---|
| INFECTIOUS | CONGENITAL |
|
|
| NONINFECTIOUS | ACQUIRED |
|
|
Congenital anatomic abnormalities should be considered, especially for infants whose persistent stridor began neonatally. Acquired obstruction can have an abrupt onset and an obvious cause (e.g., foreign body aspiration, necrotizing tracheobronchitis in ventilated neonates) or more insidious onset and an inapparent cause (e.g., expanding laryngotracheal papillomas or hemangioma, an extrinsic compressing mass). The younger the infant, the more likely that sudden obstruction, apnea, or feeding difficulties overshadow a singular complaint of stridor.
Clinical Features of Acute Infectious Causes
Recognition, avoidance of precipitating sudden airway occlusion, and urgent, expert intervention to establish an airway when indicated are paramount to avert disastrous outcomes of acute upper airway obstruction. Table 21.4 shows characteristic features of infectious causes of stridor and acute airway obstruction.35, 36, 37, 38, 39, 40, 41, 42 Viral laryngotracheitis (i.e., infectious croup) or laryngotracheobronchitis due to parainfluenza viruses, especially type 1, is by far the most common.35, 36 Influenza viruses, RSV, adenoviruses, measles, MPV, and other viruses typically cause symptomatic disease elsewhere in the respiratory tract, but during epidemic seasons, stridor is the predominant feature in a minority of infected children.
TABLE 21.4.
Differentiating Infectious Causes of Upper Airway Obstruction
| Characteristic | Viral Laryngotracheitis | Epiglottitis or Supraglottitis | Bacterial Tracheitis | Retropharyngeal Abscess |
|---|---|---|---|---|
| HISTORY | ||||
| Peak age | 6–36 mo | <6 yr, any | 2–4 yr, any | 2−4 yr |
| Peak season | Late fall, late spring | Any | Fall, winter; any | Any |
| Prodrome | Viral illness | Uncommon | Viral illness | Uncommon |
| Onset of stridor | Gradual | Abrupt | Abrupt | Abrupt |
| PHYSICAL EXAMINATION | ||||
| Peak temperature (°C) | 38–39 | >39 | >39 | >39 |
| Predominant findings | Brassy or barking cough, stridor | Toxicity, stridor | Toxicity, stridor | Toxicity, stridor |
| Associated findings | Bark, rhinorrhea | Sore throat, odynophagia, dysphagia, anxiety, drooling | Brassy cough, anxiety | Lethargy, dysphagia, drooling, trismus |
| Voice | Hoarse, raspy | Normal, muffled, mute | Hoarse, raspy | Muffled, mute |
| Position | Any; thrashing | Tripod or sniffing position; stillness; refusing to lie flat | Any; thrashing | Sniffing position; stillness; reluctance to move neck |
| Airway occlusion | Predictable from degree of stridor | Sudden | Sudden | Sudden |
| Response to racemic epinephrine | Yes, with rebound | No | No or partial | No |
| LABORATORY TESTS | ||||
| Peripheral neutrophils | Normal or low | High | Immature | Immature |
| RADIOGRAPHY | ||||
| Hypopharynx | Distended | Distended | Distended | Anteriorly displaced |
| Airway | Subglottic narrowing steeple sign; edema cords | Enlarged epiglottis (thumb sign) and aryepiglottic folds | Subglottic narrowing; irregular trachea ± intraluminal membranes | Prevertebral soft tissue mass with anterior displacement of airway (not valid sign for expiratory film, flexed neck) |
| ENDOSCOPY | ||||
| Examination findings | Red, edematous subglottis and lateral tracheal walls; crusting pseudomembrane | Red, edematous supraglottic structures | Red, edematous, eroded trachea and bronchi; thick purulence, pseudomembrane | Bulging mass in posterior pharyngeal wall; purulence |
| ETIOLOGY | ||||
| Agents | Parainfluenza viruses, especially type 1 (epidemic); other viruses (sporadic) | Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae b and other Haemophilus spp., Staphylococcus aureus | Staphylococcus aureus, Streptococcus pyogenes, Streptococcus pneumoniae | Streptococcus pyogenes; Staphylococcus aureus; rare Streptococcus pneumoniae; other oral flora |
Bacterial tracheitis usually is a complication of viral laryngotracheitis (with concordant peak age and season) but can occur at any age or as a complication of oropharyngeal surgery.43 S. aureus is the most common cause, followed by S. pyogenes; the role of anaerobic bacteria is less clear.41, 43 With the universal use of H. influenzae b vaccine, epiglottitis is a rare cause of stridor; current cases of supraglottitis are more likely to affect the aryepiglottic region and to be caused by streptococci and staphylococci. Other agents, including Fusobacterium spp. and other anaerobes that can cause parapharyngeal and retropharyngeal infections in children, must be considered because the incidence is increasing42, 44, 45 (see Chapter 28).
The history surrounding the onset of stridor and the patient's age and examination findings are the most helpful clues to the likely site and cause of infection. The child with viral laryngotracheitis usually has had 2 to 3 days of a typical URI when cough worsens and stridor begins. The child with bacterial tracheitis usually has had a similar background illness and then has sudden onset of high fever, toxicity, and rapid progression to airway obstruction. The young child with retropharyngeal abscess or adolescent with peritonsillar abscess has less stridor but refuses to swallow and has a muffled voice, reluctance to move the neck, and a guarded posture to maximize oropharyngeal airway patency. Trismus is an expected and useful finding in patients with peritonsillar abscess and some lateral pharyngeal space infections of odontogenic origin.38 Epiglottitis and supraglottitis cause the patient to guard anxiously in a sitting posture with arms back, jaw forward, and chin raised (i.e., sniffing position) to maximize lift of the epiglottis away from the airway. In contrast, subglottic, tracheal obstruction cannot be lessened by position; patients with laryngotracheitis or bacterial tracheitis thrash about with the anxiety of suffocation.
The expected course36, 46, 47 and sequelae of acute infectious airway obstruction are shown in Table 21.5 . Children with viral laryngotracheitis are less prone to sudden complete obstruction; the hourly course is predictable by degree of stridor and adequacy of aeration. The response to racemic epinephrine and dexamethasone therapy usually averts intubation.48 In a systematic review of children with croup, symptoms resolved in 2 days for 90%.12 Establishment of an artificial airway is urgently required for almost all patients with stridor due to acute supraglottitis and bacterial tracheitis and for many with retropharyngeal infection. The course of disease in children with bacterial tracheitis can be further complicated because infection (and obstructive consequences) commonly extends the length of the trachea and below.
TABLE 21.5.
Expected Course and Sequelae of Acute Infectious Upper Airway Obstruction
| Characteristic | Viral Laryngotracheitis | Supraglottitis, Epiglottitis | Bacterial Tracheitis | Retropharyngeal Abscess |
|---|---|---|---|---|
| Artificial airway (% of cases) | <1 | >90 | >75 | <50 to >75a |
| Median intubation period | 4 days | 2 days | 6 days | 2 days |
| Airway occlusion after intubation | Rare | No | Yes | No |
| Death during hospitalization | No | No | Yes | No |
| Airway sequelae (% of cases) | <3 | Rare | <3 | No |
Varies according to age and site (e.g., higher retropharyngeal; lower in older, parapharyngeal and surgical drainage)
Cough
Characteristics
Cough is a critical protective mechanism to expel particulate matter from the larynx and trachea and is a cardinal sign of infectious and noninfectious respiratory tract and nonrespiratory tract disorders. Occasional acute, life-threatening infectious and noninfectious causes may be overlooked unless the clinician adopts a disciplined diagnostic approach. Careful assessment of a pathologic cough—its onset, duration, clinical context, association with other findings, specific timbre, pattern, and productivity—frequently predicts the site of pathophysiology and narrows the differential diagnosis to a limited number of entities.
Cough usually is defined as acute (<3 weeks), subacute (3–8 weeks), or chronic (>8 weeks). A wet or moist cough in children, frequently referred to as productive, is associated with detectable secretions by bronchoscopy and can be reported accurately by parents and clinicians.47
Etiology
A dry cough is expected in allergic rhinitis/sinusitis and asthma, and a wet cough is typical in infectious sinusitis, bronchiolitis, bronchiectasis, and pneumonia. In a systematic review of self-limited URIs, acute cough symptoms resolved by day 10 after onset in 50% and by day 25 after onset in 90% of children.12 Isolated subacute cough (in absence of other symptoms), which usually is dry and follows a viral infection, frequently is related to increased cough receptor sensitivity.49 Chronic cough (≥8 weeks) is pathologic. If the durations of 4 to 8 weeks are included, many coughs are postinfectious and resolve spontaneously.50, 51, 52
The differential diagnosis can be focused by age, history, and clinical findings. The algorithms for sequential evaluation and management sometimes are complex50, 51, 53, 54 and best performed by a pediatric pulmonologist. Most common causes of chronic cough in older children are allergic or nonallergic rhinitis and sinusitis, asthma, protracted bacterial bronchitis, and gastroesophageal reflux disease.50, 51, 52, 53, 54, 55, 56 An important minority of children have cystic fibrosis, non– cystic fibrosis bronchiectasis, immunodeficiency disorders, or ciliary dyskinesia. These diagnoses are considered especially in the preschool-age child with chronic cough.53
Management focuses on determining the cause. No evidence supports the use of medications aimed at symptomatic relief of acute or chronic cough, and some data suggest harmful effects are possible.
Cough should not be accepted as a sign of a self-limited URI in infants younger than 3 months of age. The mnemonic CRADLE, which is used to recall the differential diagnoses for cough in infants,57 refers to cystic fibrosis (C); respiratory tract infections (R), especially pneumonia and pertussis; aspiration (A) due to swallowing dysfunction, gastroesophageal reflux, or tracheoesophageal fistula; ciliary dyskinesia (D); lung, vascular, or airway malformations (L); and edema (E) due to heart failure or pulmonary lymphangiectasia.
Table 21.6 provides a framework for consideration of cough illnesses. There is considerable overlap in symptoms of cough caused by certain infectious agents, such as Bordetella pertussis or Mycoplasma pneumoniae in adolescents58 because of a common tracheobronchial site of pathophysiology and frequent dual infections.59 B. pertussis causes a dramatic, debilitating, paroxysmal cough without airway or lower tract abnormalities (unless secondary pneumonia occurs, leading to fever and toxicity), whereas Chlamydia trachomatis causes pneumonia with prominent tachypnea: the cough is important only because it brings the child to medical attention (see Chapters 162 and 167). Diagnosis of pneumonia is based on signs of lower respiratory tract involvement, such as tachypnea and retractions, in addition to cough, and the likely causative agent is determined from the constellation of clinical findings (Tables 21.7 and 21.8 ).
TABLE 21.6.
Differentiating Among Causes of Cough
| Cause | Peak Age | Nature of Cough | Cough as Dominant Feature | Anticipated or Associated Findings |
|---|---|---|---|---|
| INFECTIONS OF THE RESPIRATORY TRACT | ||||
| Viral laryngotracheitis | <5 yr | Brassy, painful | Yes | Hoarse, raspy voice; viral URI complexa |
| Viral laryngotracheitis or laryngotracheobronchitis | 6–36 mo | Barking, brassy | Codominant with stridor | Stridor, hoarseness, viral URI complexa |
| Mycoplasma pneumoniae | Adolescent | Hacking, paroxysmal, painful | Yes | Prodromal, fever, headache, myalgia; then gradual worsening cough; crackles |
| Pertussis | Infancy, adolescence | Sudden paroxysm of explosive, machine-gun bursts (15–30 per breath) when beyond neonatal age | Yes | Bulging, watering eyes during paroxysm, posttussive emesis; skin and conjunctival hemorrhages; afebrile, without lower respiratory tract symptoms or symptoms between paroxysms |
| Chlamydia trachomatis pneumonia | 1–3 mo | Staccato, dry (single cough per breath) | Yes | History can include prior/concurrent conjunctivitis; afebrile, tachypnea, crackles |
| Bronchiolitis | 4 mo–2 yr | High-pitched or grunt | No | Wheezing, rhinorrhea, respiratory distress; ± fever |
| Pneumonia (bacterial or viral) | Any | Wet, productive or nonproductive | Codominant with respiratory distress | Tachypnea, rales, respiratory distress; fever |
| Pleurodynia | Any | Inspiratory hitch; expiratory grunt | Codominant with chest pain | Chest pain; costochondral tenderness |
| Sinusitis | Any | Irritative; occurs during day and worsens at night | Sometimes | Mucopurulent rhinorrhea, postnasal discharge; facial pain, swelling, or tenderness; headache; ± fever |
| Tracheoesophagitis (fungal or viral) | Any | Irritative | No | Odynophagia or dysphagia; immune-compromised host; hoarseness; oropharyngeal lesions |
| Cystic fibrosis | <2 yr; any | Wet, productive; paroxysmal, hacking | Sometimes | Poor growth; persistent and recurrent sinusitis, pneumonia; digital clubbing |
| Protracted bronchitis | Any; mean, 8–9 yr | Wet, productive; >8 wk | Yes | Bronchoscopy; neutrophils, bacteria, cytokines; response to antibiotic |
| OTHER CONDITIONS | ||||
| Purulent pericarditis | Any | Grunt | Sometimes | Fever, toxicity, respiratory distress or dyspnea; displaced point of maximum impulse; muffled heart sounds |
| Myocarditis | Any | Grunt | Sometimes | Fatigue, dyspnea, tachypnea; ± fever |
| Congestive heart failure | Any | Grunt, wet, or brassy | Sometimes | Fatigue, dyspnea, sweating, tachycardia, tachypnea; ± fever; distended neck veins, liver |
| NONINFECTIOUS AIRWAY ABNORMALITIES | ||||
| Gastroesophageal reflux | 6 wk–6 mo | High-pitched, dry | Codominant with other symptoms | Stridor, choking, gagging, irritability, arching (Sandifer syndrome) ± regurgitation, pneumonia |
| Reactive airway, asthma | 6 mo–adolescence | Irritative dry, repetitive (not paroxysmal); night especially | Sometimes | Atopic, precipitants, seasonal; ± wheezing; response to β-agonist |
| Congenital vascular rings, pulmonary sling | Infancy | Brassy | No | Stridor; onset of symptoms in first month of life |
| Compression on airway or glossopharyngeal or phrenic nerve | Any | Irritative, dry | Sometimes initially | Can be positional (tumors, other masses), associated with other neuropathies, stridor, changes in phonation |
| Habit cough | Adolescence | Vibratory, low-pitched, honking; disappears with sleep | Yes, sole feature | “La belle indifference”; family dynamics and other somatization |
Viral upper respiratory tract infection (URI) complex consists of fever, rhinorrhea, sore throat, conjunctivitis, exanthem, and enanthem.
TABLE 21.7.
Symptoms and Signs of Pneumonia
| Symptoms | Signs | Physical Examination Findings |
|---|---|---|
|
|
|
TABLE 21.8.
Clinical Features of Pneumonia in Infants Younger Than 3 Months
| Characteristic | Respiratory Syncytial Virus | Other Respiratory Viruses | Chlamydia trachomatis | Pertussisa |
|---|---|---|---|---|
| HISTORY | ||||
| Season | Winter | Unique to each | Any | Any; peak July–October |
| Onset | Acute, days | Acute, days | Insidious | Progressive, days |
| Illness in others | URI | URI, flu, croup | No | Cough |
| Fever | Half of cases | Most cases | No | No |
| Cough | Yes | Yes | Yes/staccato | Yes/paroxysmal |
| Associated features | Apnea, URI | URI, croup, conjunctivitis | Conjunctivitis (prior or current) | Apnea, cyanosis, posttussive emesis |
| PHYSICAL EXAMINATION | ||||
| Predominant feature | Respiratory distress | Respiratory distress | Cough | Cough |
| General appearance | Ill, not toxic | Ill, not toxic | Well, tachypneic | Well between paroxysms |
| Degree of illness: respiratory findings | Degree of illness = findings | Degree of illness = findings | Findings > degree of illness | Ill only during cough |
| Auscultation | Wheezes, coarse crackles | Crackles, wheezes | Diffuse crackles | Clear |
| LABORATORY STUDIES | ||||
| Chest radiograph | Hyperaeration, subsegmental atelectasis, peribronchial cuffing | Hyperaeration, ± peribronchial thickening, ± diffuse interstitial infiltrates | Hyperaeration, diffuse alveolar and interstitial infiltrates | Normal or perihilar infiltrate |
| White blood cell count | Normal or lymphocytosis | Normal, lymphocytosis, neutropenia | Eosinophilia | Lymphocytosis; no eosinophilia |
| Other findings | Hypoxemia | — | Increases in IgG, IgA, IgM | — |
| Diagnostic tests | Nasal wash EIA, DFA, PCR | Nasal wash EIA, DFA, PCR | Conjunctival, NP DFA, EIA | NP, PCR, culture |
DFA, direct fluorescent antibody (test); EIA, enzyme immunoassay; Ig, immunoglobulin; NP, nasopharyngeal specimen; PCR, polymerase chain reaction; URI, upper respiratory tract infection.
Pertussis is included in this table because it should be considered in young infants with cough and respiratory distress, although pneumonia is characteristically absent.
Protracted bacterial bronchitis is inadequately studied, but it may be an underdiagnosed cause of chronic wet cough for which antibiotic therapy may be appropriate.60 Confirmation rests on bronchoscopic findings of dense bacteria and an acute neutrophilic inflammatory response.61 Because isolated bacteria are those found commonly in oropharyngeal flora, acute otitis media, and sinusitis, some pulmonologists prescribe a diagnostic or therapeutic trial of amoxicillin-clavulanate for 2 weeks for patients with a typical isolated episode of chronic cough.
Tachypnea and Other Signs of Lower Respiratory Tract Disorders
Tachypnea can be a voluntary or involuntary response to anxiety, fright, or pain; an abnormal breathing pattern related to central nervous system dysfunction; or the physiologic response to increased temperature or metabolic state. Most commonly, tachypnea is the response to respiratory acidosis or hypoxemia of acute infection or the attempt to restore pH balance during metabolic acidosis (e.g., diabetes, salicylate poisoning, dehydration). Metabolic causes should not be forgotten while the clinician pursues the much more likely primary pulmonary causes. Tachypnea can result from primary cardiac abnormalities (e.g., congestive heart failure, cyanotic congenital heart disease), pulmonary vascular abnormalities (e.g., cardiac shunts, capillary dilatation, hemorrhage, obstructed return to the heart, infarction), impaired lymphatic flow (e.g., congenital lymphangiectasia, tumor), or pleural fluid collections (e.g., hemorrhagic, purulent, transudative or lymphatic fluid, an infusion from a misplaced vascular catheter).
Clinical practice guidelines for management of community-associated pneumonia in infants and children by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America include an excellent literature review of clinical findings.62 Table 21.7 shows symptoms and signs of pneumonia in infants and children. Tachypnea is thought to be the best clinical predictor of lower respiratory tract infection in children. The World Health Organization (WHO) defines pneumonia primarily as cough or difficult breathing and tachypnea. The definition of tachypnea is related to age, with a respiratory rate of >60 breaths/min in infants aged 0 to 2 months, >50 in infants 2 to 12 months, >40 in children 1 to 5 years, and >20 in children older than 5 years of age.63, 64
Tachypnea has a sensitivity of 50% to 85% for the diagnosis of lower respiratory tract infection and a specificity of 70% to 97%.65, 66 At less than 24 months of age, the younger the patient, the less likely that pneumonia is the diagnosis if tachypnea is absent. In one study, for infants younger than 2 months of age, a respiratory rate of 60 breaths/min, retractions, or nasal flaring had sensitivity for the diagnosis of pneumonia of 91%.66 In a study from a U.S. emergency department of children younger than 5 years who were undergoing chest radiography for possible pneumonia, respiratory rates in those with or without documented pneumonia did not differ significantly. However, 20% of those with WHO-defined tachypnea had pneumonia confirmed compared with 12% of those who did not.67
Obtaining chest radiographs for febrile infants without an apparent focus of infection to exclude pneumonia missed by physical examination has a low yield in the absence of tachypnea.68, 69 Cough is a more sensitive but nonspecific symptom of pneumonia. Other symptoms and signs associated with pneumonia, such as nasal flaring, intercostal retractions, and cyanosis, have lower sensitivity (25%, 9%, and 9%, respectively) but high specificity (87%, 93%, and 94%, respectively).65 Although fever, cough, and tachypnea are cardinal features, they can be overshadowed or overlooked in patients who come to medical attention for pneumonia-associated stiff neck, abdominal pain, or chest pain or for nonspecific symptoms of illness, such as feeding difficulty in infants. Although a chest radiograph is not routinely needed for children with any of these complaints, it should be considered if the patient has fever and cough or tachypnea.70, 71 Classic symptoms of pneumonia reported in adolescents and adults are fever, chills, pleuritic chest pain, and cough that produces purulent sputum, with less noticeable tachypnea.
Grunting is an expiratory sound produced in the larynx when vocal cords are adducted to generate positive end-expiratory pressure (i.e., self-induced PEEP) and increased resting volume of the lung. Its causes are myriad but never trivial. Grunting can be a sign of surfactant deficiency in the neonate or of pulmonary edema, foreign body aspiration, severe pneumonia, mediastinal mass or severe mediastinal shift from any cause, pleuritic or musculoskeletal chest pain, or myopericarditis or other cardiac abnormalities at any age.72 Retractions (i.e., intercostal, subcostal, or suprasternal) and grunting have been associated with severe pneumonia, and nasal flaring and head bobbing with hypoxemia.
Adventitial respiratory sounds usually indicate lower respiratory tract disease, pulmonary edema, or hemorrhage. Wheezes are continuous musical sounds made predominantly on expiration and are a sign of airway obstruction. Widespread bronchiolar narrowing, as most commonly occurs with the inflammation of virus-associated lower respiratory tract infection, produces heterophonous, high-pitched, sibilant wheezes of variable pitch and presence in different lung fields.73 Fixed obstruction in a larger airway, as from a foreign body or anomaly, produces a homophonous, monotonous wheeze. The rate of radiographically confirmed pneumonia among children with wheezing is low (<5% overall and 2% in the absence of fever).70
Rhonchi, sometimes also called low-pitched wheezes or coarse crackles, are nonrepetitive, nonmusical, low-pitched sounds frequently produced during early inspiration and expiration that usually are a sign of turbulent airflow through secretions in large airways. Fine crackles, the term preferred by pulmonologists over rales (which has a variety of meanings in different languages) are high-pitched, low-amplitude, end-inspiratory, discontinuous popping sounds indicative of the opening of peripheral air-fluid interfaces. Fine crackle is the auscultatory finding suggesting the diagnosis of pneumonia.
Auscultatory abnormalities of crackles and wheezing have disparate diagnostic usefulness in various studies, depending on the categorization of bronchiolitis. Tachypnea is a more sensitive finding than crackles for bacterial pneumonia; wheezing is more sensitive than tachypnea for bronchiolitis.
Diminished or distant breath sounds, dullness to percussion, and decreased vocal fremitus indicate parenchymal pulmonary consolidation, pleural mass, or fluid collection. Bronchial (tubular) breath sounds have a low-pitched sound of similar intensity throughout inspiration and expiration, as is heard normally in the intrascapular area. Bronchial breath sounds, dullness to percussion, and increased vocal fremitus over an anatomically (tubular) confined lung field indicate parenchymal consolidation, atelectasis, or another continuous tissue or fluid density juxtaposed between a bronchus and the chest wall.
Radiographic infiltrates have been reported in 5% to 19% of children with fever in the absence of symptoms or signs of lower respiratory tract infection.74, 75 Rate of pneumonia deemed occult fell from 15% to 9% after universal vaccination with 7-valent pneumococcal conjugate vaccine (PCV7) in one study.70 Clinical features associated with occult pneumonia in another study included cough, fever of more than 5 days' duration, fever greater than 39°C, and leukocytosis greater than 20,000 cells/mm3; only 5% of children without cough had radiographically confirmed pneumonia.74
Differentiating Features of Pneumonia
Pneumonia in Young Infants
In young infants, acute infection with bacterial and nonbacterial respiratory tract pathogens frequently leads to lower respiratory tract infection. Except in the first few days of life, when pneumonia predominantly is caused by bacteria acquired from the mother's genital tract or organisms acquired transplacentally, nonbacterial pathogens are overwhelmingly predominant.72 As perinatally acquired agents persist, community exposures increase, and maternally derived antibody protection wanes, the infant between 3 weeks and 3 months of age is vulnerable to a unique array of lower respiratory tract pathogens.76
The clinical setting, specific symptom complex, and severity of illness in proportion to findings on physical examination aid identification of likely causes and guide the diagnostic and therapeutic approach (see Table 21.8). Although the pathogens listed in Table 21.8 frequently are referred to as causing afebrile pneumonia, this is a misnomer because B. pertussis infrequently causes lower respiratory tract abnormalities, and RSV and especially other respiratory viruses frequently cause fever.11, 72, 77, 78 A causal role for Ureaplasma urealyticum is not completely defined because the situation is confounded by the asymptomatic presence of this organism in women and young infants. Pneumonia due to Pneumocystis jirovecii probably is confined to infants with severe debilitation or immune defects.
Pneumonia in Older Infants, Children, and Adolescents
Table 21.9 categorizes the features of acute pneumonia in older infants, children, and adolescents by cause. No single fact in the medical history or examination finding is unique for any agent, but when taken together, a working diagnosis emerges and guides intervention or further diagnostic testing. Chest radiography and laboratory tests usually are reserved for patients who are ill and hospitalized or whose clinical picture is not compelling for a category of etiologic agents.
TABLE 21.9.
Clinical Features of Acute Pneumonia in Children and Adolescents
| Characteristic | Bacteria | Virus | Mycoplasma | Tuberculosis |
|---|---|---|---|---|
| HISTORY | ||||
| Age | Any; infants especially | Any | School age | Any; <4 yr and 15–19 yr especially |
| Temperature (°C) | Most ≥39 | Most <39 | Most <39 | Most <39 (unless empyema) |
| Onset | Abrupt | Gradual | Worsening cough | Insidious cough |
| Others in home ill | No | Yes, concurrent; upper respiratory tract infection, rash, conjunctivitis | Yes, weeks apart; pharyngitis, flulike illness, cough | Yes, persistent cough |
| Associated signs, symptoms | Toxicity, rigors | Myalgia, rash, mucous membrane involvement | Headache, sore throat, chills, myalgia, rash, pharyngitis, myringitis, chest pain | Weight loss, night sweats (late) |
| Cough | Wet, productive | Nonproductive | Hacking, paroxysmal, usually nonproductive | Irritative or productive |
| PHYSICAL EXAMINATION | ||||
| Predominant feature | Toxicity, respiratory distress | Respiratory distress | Cough | Persistent cough |
| Degree of illness: respiratory finding | Degree of illness > findings | Degree of illness ≥ findings | Degree of illness < findings | Well: no findings (+ cough); ill with findings |
| Pleuritic chest pain | No/yes | No | No | No/occasional |
| Auscultation | Unilateral, anatomically confined crackles or none; dullness, diminished or bronchial/tubular sounds | Diffuse, bilateral crackles, wheezes, rhonchi | Unilateral, anatomically confined crackles; ± wheezes | Most normal; or unilateral crackles ± dullness |
| LABORATORY STUDIES | ||||
| Chest radiograph | Hyperaeration, patchy alveolar infiltrate or consolidation in lobe, segment, subsegment | Hyperaeration, interstitial infiltrate in diffuse or perihilar distribution; “wandering” atelectasis | Patchy alveolar and/or interstitial infiltrate in single or contiguous, usually unilateral lower lobe or lobes; perihilar adenopathy | Patchy alveolar infiltrate in single or contiguous lobes with disproportionate hilar adenopathy; miliary or lobar consolidation |
| Pleural fluid | No/yes (large) | No/yes (small) | No/yes (small to moderate) | No/yes (small, large) |
| Peripheral white blood cell count (cells/mm3) | Most cases >15,000; neutrophils ± bands | Most cases <15,000; lymphocytes | Most cases <15,000; neutrophils | Most cases <15,000; neutrophils, monocytes |
| Sputum | Copious, purulent; neutrophils, abundant bacteria | Scant mucoid; epithelial, mononuclear cells | Scant mucoid; mixed mononuclear cells/neutrophils | Scant to copious; neutrophils (if copious) |
| Diagnostic tests | Sputum Gram stain, culture; blood culture | Nasal wash, throat, bronchoscopy specimen for antigen detection, polymerase chain reaction (PCR); acute and convalescent serology | Throat, nasal, bronchoscopy specimen for PCR; cold agglutinins (≥12 years); acute and convalescent serology | Gastric aspirate; sputum stain and culture; tuberculin skin test or interferon γ release assay (IGRA) (≥5 yr old) |
Several studies using complex diagnostic methods have confirmed the specific cause of pneumonia in 45% to 85% of cases.77, 78, 79, 80, 81 Viral causes predominate, and most are amenable to diagnosis.77 The efficacy trial and postmarketing studies of PCV7 infer that Streptococcus pneumoniae is a relatively common cause of pneumonia with patchy or consolidative infiltrates.82, 83 Use of the urine antigen detection test in children with lobar pneumonia also supports the important role of S. pneumoniae 84; however, the test is positive for more than 15% of children with asymptomatic colonization and not recommended for diagnosis.85
A Cochrane systematic review of clinical symptoms and signs of Mycoplasma pneumonia found the absence of wheezing and presence of chest pain were significant associations.86 Serologic testing for M. pneumoniae using an IgM enzyme immunoassay is problematic because of false-positive test results.62, 87 Detection in throat or nasal specimens using polymerase chain reaction methods is highly sensitive, but the meaning requires clinical interpretation and further study. Ascribing a causal role of pneumonia to Chlamydophila pneumoniae is confounded by the findings of prolonged asymptomatic carriage and inconsistent serologic results among studies.88
Hemoptysis
Hemoptysis, defined as coughing up blood that originated below the larynx, is uncommon in children. More commonly, blood originates from the upper airway due to epistaxis or other sources. Mechanisms of hemoptysis include bleeding from congenital or acquired abnormal bronchial or pulmonary blood flow, venous obstruction, or vascular abnormalities; immune-mediated endothelial damage; or infectious or traumatic erosion of tracheal, bronchial, or bronchiolar epithelium. Hemorrhage can be mild (e.g., tracheitis, tracheobronchitis) or massive (e.g., congenital malformations, foreign body, bronchiectasis, pulmonary hemosiderosis).
Causes of hemoptysis in children are listed in Table 21.10 . Infection is a common cause of hemoptysis, including pneumonia from various causes, including tuberculosis and Aspergillus. In a 10-year retrospective study from Texas Children's Hospital, cystic fibrosis patients accounted for 68% of hemoptysis episodes overall.89
TABLE 21.10.
Causes of Hemoptysis in Children
| Epithelial Damage | Vascular Abnormality or Damage |
|---|---|
|
|
A chest radiograph, bronchoscopy, coagulation studies, and computed tomography are useful diagnostic modalities in most cases of hemoptysis. If negative, a cardiac evaluation including echocardiography and studies for autoimmune vasculitides may be indicated. Digital subtraction angiography, pulmonary arteriography, or lung biopsy may be indicated.
All references are available online at www.expertconsult.com .
Key References
- 7.Byington CL, Ampofo K, Stockmann C. Community Surveillance of Respiratory Viruses Among Families in the Utah Better Identification of Germs-Longitudinal Viral Epidemiology (BIG-LoVE) Study. Clin Infect Dis. 2015;61:1217–1224. doi: 10.1093/cid/civ486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Roberts G, Xatzipsalti M, Borrego LM. Paediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology. Allergy. 2013;68:1102–1116. doi: 10.1111/all.12235. [DOI] [PubMed] [Google Scholar]
- 12.Thompson M, Vodicka TA, Blair PS. Duration of symptoms of respiratory tract infections in children: systematic review. BMJ. 2013:347–366. doi: 10.1136/bmj.f7027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.DeMuri GP, Gern JE, Moyer SC. Clinical features, virus identification, and sinusitis as a complication of upper respiratory tract illness in children 4−7 years. J Pediatr. 2016;171:133–139. doi: 10.1016/j.jpeds.2015.12.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Chow AW, Benninger MS, Brook I. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis. 2012;54:1041–1045. doi: 10.1093/cid/cir1043. [DOI] [PubMed] [Google Scholar]
- 27.Wald ER, Applegate KE, Bordley C. Clinical practice guideline for the diagnosis and management of acute bacterial sinusitis in children aged 1 to 18 years. Pediatrics. 2013;132:e262–e280. doi: 10.1542/peds.2013-1071. [DOI] [PubMed] [Google Scholar]
- 50.Shields MD, Doherty GM. Chronic cough in children. Paediatr Respir Rev. 2013;14:100–106. doi: 10.1016/j.prrv.2012.05.002. [DOI] [PubMed] [Google Scholar]
- 62.Bradley JS, Byington C, Shah SS. The management of community-acquired pneumonia (CAP) in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53:e25–e76. doi: 10.1093/cid/cir531. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Meissner HC. Viral bronchiolitis in children. N Engl J Med. 2016;374:62–72. doi: 10.1056/NEJMra1413456. [DOI] [PubMed] [Google Scholar]
- 86.Wang K, Gill P, Perera R. Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia. Cochrane Database Syst Rev. 2012;(10) doi: 10.1002/14651858.CD009175.pub2. CD009175. [DOI] [PMC free article] [PubMed] [Google Scholar]
References
- 1.Mainous AG, Hueston WJ, Eberlein C. Colour of respiratory discharge and antibiotic use. Lancet. 1997;350:1077. doi: 10.1016/S0140-6736(05)70457-8. [DOI] [PubMed] [Google Scholar]
- 2.Wald ER, Guerra N, Byers C. Upper respiratory tract infections in young children: duration of and frequency of complications. Pediatrics. 1991;87:129–133. [PubMed] [Google Scholar]
- 3.Nyquist A-C, Gonzales R, Steiner JF. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA. 1998;279:875–877. doi: 10.1001/jama.279.11.875. [DOI] [PubMed] [Google Scholar]
- 4.Mainous AG, Hueston WJ, Love MM. Antibiotics for colds in children. Arch Pediatr Adolesc Med. 1998;152:349–350. [PubMed] [Google Scholar]
- 5.Hersch AL, Jackson MA, Hicks LA, Committee on Infectious Diseases Principles of judicious antibiotic prescribing for upper respiratory tract infections in pediatrics. Pediatrics. 2013;132:1146–1154. doi: 10.1542/peds.2013-3260. [DOI] [PubMed] [Google Scholar]
- 6.Makela MJ, Puhakka T, Ruuskanen O. Viruses and bacteria in the etiology of the common cold. J Clin Microbiol. 1998;36:539–542. doi: 10.1128/jcm.36.2.539-542.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Byington CL, Ampofo K, Stockmann C. Community Surveillance of Respiratory Viruses Among Families in the Utah Better Identification of Germs-Longitudinal Viral Epidemiology (BIG-LoVE) Study. Clin Infect Dis. 2015;61:1217–1224. doi: 10.1093/cid/civ486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Schidlow DV. Primary ciliary dyskinesia (the immotile cilia syndrome) Ann Allergy. 1994;73:457–468. doi: 10.1016/b978-0-323-01909-5.50015-3. [DOI] [PubMed] [Google Scholar]
- 9.Philip G, Togias AG. Allergic rhinitis: clues to the differential. J Respir Dis. 1995;16:359–366. [Google Scholar]
- 10.Roberts G, Xatzipsalti M, Borrego LM. Paediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology. Allergy. 2013;68:1102–1116. doi: 10.1111/all.12235. [DOI] [PubMed] [Google Scholar]
- 11.Putto A, Ruuskanen O, Meurman O. Fever in respiratory virus infections. Am J Dis Child. 1996;140:1159–1163. doi: 10.1001/archpedi.1986.02140250085040. [DOI] [PubMed] [Google Scholar]
- 12.Thompson M, Vodicka TA, Blair PS. Duration of symptoms of respiratory tract infections in children: systematic review. BMJ. 2013:347–366. doi: 10.1136/bmj.f7027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.DeMuri GP, Gern JE, Moyer SC. Clinical features, virus identification, and sinusitis as a complication of upper respiratory tract illness in children 4−7 years. J Pediatr. 2016;171:133–139. doi: 10.1016/j.jpeds.2015.12.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Todd JK, Todd N, Damato J. Bacteriology and treatment of purulent nasopharyngitis: a double blind, placebo-controlled evaluation. Pediatr Infect Dis. 1984;3:226–232. doi: 10.1097/00006454-198405000-00009. [DOI] [PubMed] [Google Scholar]
- 15.Stineweg KK. Natural history and prognostic significance of purulent rhinitis. J Fam Pract. 1983;17:61–64. [PubMed] [Google Scholar]
- 16.King S, Glanville J, Sanders ME. Effectiveness of probiotics on the duration of illness in health children and adults who develop common acute respiratory infectious conditions: a systematic review and meta-analysis. Br J Nutr. 2014;112:41–54. doi: 10.1017/S0007114514000075. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Wald ER, Milmore GJ, Bowen AD. Acute maxillary sinusitis in children. N Engl J Med. 1981;304:749–754. doi: 10.1056/NEJM198103263041302. [DOI] [PubMed] [Google Scholar]
- 18.Wald ER, Chiponis D, Ledesma-Medina J. Comparative effectiveness of amoxicillin and amoxicillin-clavulanate potassium in acute paranasal sinus infections in children: a double-blind, placebo-controlled trial. Pediatrics. 1986;77:795–800. [PubMed] [Google Scholar]
- 19.Brook I. Microbial dynamics of purulent nasopharyngitis in children. Int J Pediatr Otorhinolaryngol. 2003;67:1047–1053. doi: 10.1016/s0165-5876(03)00203-9. [DOI] [PubMed] [Google Scholar]
- 20.Long SS, Teter MJ, Henretig FN. Nasopharyngeal flora in children with acute otitis media. Infect Immun. 1983;41:987–991. doi: 10.1128/iai.41.3.987-991.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Zenni A, Cheatham A, Thompson A. Streptococcus pneumoniae colonization in the young child: association with otitis media and resistance to penicillin. J Pediatr. 1995;127:533–537. doi: 10.1016/s0022-3476(95)70108-7. [DOI] [PubMed] [Google Scholar]
- 22.Spurling GK, Del Mar CB, Dooley L. Delayed antibiotics for respiratory infections. Cochrane Database Syst Rev. 2013;(4) doi: 10.1002/14651858.CD004417.pub3. CD004417. [DOI] [PubMed] [Google Scholar]
- 23.Brodsky L. Tonsillitis/adenoiditis: the clinical work-up. J Respir Dis. 1990;11:19–28. [Google Scholar]
- 24.Smith MJ. Evidence for the diagnosis and treatment of acute uncomplicated sinusitis in children: a systematic review. Pediatrics. 2013;132:e284–e296. doi: 10.1542/peds.2013-1072. [DOI] [PubMed] [Google Scholar]
- 25.Wald ER, Nash D, Eickhoff J. Effectiveness of amoxicillin/clavulanate potassium in the treatment of acute bacterial sinusitis in children. Pediatrics. 2009;124:9–15. doi: 10.1542/peds.2008-2902. [DOI] [PubMed] [Google Scholar]
- 26.Chow AW, Benninger MS, Brook I. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis. 2012;54:1041–1045. doi: 10.1093/cid/cir1043. [DOI] [PubMed] [Google Scholar]
- 27.Wald ER, Applegate KE, Bordley C. Clinical practice guideline for the diagnosis and management of acute bacterial sinusitis in children aged 1 to 18 years. Pediatrics. 2013;132:e262–e280. doi: 10.1542/peds.2013-1071. [DOI] [PubMed] [Google Scholar]
- 28.Smith TD, Wilkinson V, Kaplan EL. Group A streptococcus-associated upper respiratory infection in a day-care center. Pediatrics. 1989;83:380–384. [PubMed] [Google Scholar]
- 29.Schwartz RH. The nasal saline flush procedure. Pediatr Infect Dis J. 1997;16:725. doi: 10.1097/00006454-199707000-00025. [DOI] [PubMed] [Google Scholar]
- 30.Wald ER, Nash D, Eickhoff J. Effectiveness of amoxicillin/clavulanate potassium in the treatment of bacterial sinusitis in children. Pediatrics. 2009;124:9–15. doi: 10.1542/peds.2008-2902. [DOI] [PubMed] [Google Scholar]
- 31.Ida JB, Thompson DM. Pediatric stridor. Otolaryngol Clin North Am. 2014;47:795–819. doi: 10.1016/j.otc.2014.06.005. [DOI] [PubMed] [Google Scholar]
- 32.Clarke A, Skelton J, Fraser RS. Fungal tracheobronchitis: report of 9 cases and review of the literature. Medicine (Baltimore) 1991;70:1–14. doi: 10.1097/00005792-199101000-00001. [DOI] [PubMed] [Google Scholar]
- 33.Kirpalani H, Higa T, Perlman M. Diagnosis and therapy of necrotizing tracheobronchitis in ventilated neonates. Crit Care Med. 1985;13:792–797. doi: 10.1097/00003246-198510000-00004. [DOI] [PubMed] [Google Scholar]
- 34.Nielson DW, Heldt G, Tooley WH. Stridor and gastroesophageal reflux in infants. Pediatrics. 1990;85:1034–1039. [PubMed] [Google Scholar]
- 35.Knott AM, Long CE, Hall CB. Parainfluenza viral infections in pediatric outpatients: seasonal patterns and clinical characteristics. Pediatr Infect Dis J. 1994;13:269–273. doi: 10.1097/00006454-199404000-00005. [DOI] [PubMed] [Google Scholar]
- 36.Henrickson KJ, Kuhn SM, Savatski LL. Epidemiology and cost of infection with human parainfluenza virus types 1 and 2 in young children. Clin Infect Dis. 1994;18:770–779. doi: 10.1093/clinids/18.5.770. [DOI] [PubMed] [Google Scholar]
- 37.Wagener JS, Landau LI, Olinsky A. Management of children hospitalized for laryngotracheobronchitis. Pediatr Pulmonol. 1986;2:159–162. doi: 10.1002/ppul.1950020308. [DOI] [PubMed] [Google Scholar]
- 38.Chow AW. Life-threatening infections of the head and neck. Clin Infect Dis. 1992;14:991–1004. doi: 10.1093/clinids/14.5.991. [DOI] [PubMed] [Google Scholar]
- 39.Gorelick MH, Baker D. Epiglottitis in children, 1979 through 1992: effects of Haemophilus influenzae type b immunization. Arch Pediatr Adolesc Med. 1994;148:47–50. doi: 10.1001/archpedi.1994.02170010049010. [DOI] [PubMed] [Google Scholar]
- 40.Long SS. Bacterial tracheitis. Pediatr Infect Dis. 1992;2:29–31. [Google Scholar]
- 41.Brook I. Aerobic and anaerobic microbiology of bacterial tracheitis in children. Clin Infect Dis. 1995;20:S222–S223. doi: 10.1093/clinids/20.supplement_2.s222. [DOI] [PubMed] [Google Scholar]
- 42.Lee SS, Schwartz RH, Bahadori RS. Retropharyngeal abscess: epiglottitis of the new millennium. J Pediatr. 2001;138:435–437. doi: 10.1067/mpd.2001.111275. [DOI] [PubMed] [Google Scholar]
- 43.Eid NS, Jones VF. Bacterial tracheitis as a complication of tonsillectomy and adenoidectomy. J Pediatr. 1994;125:401–402. doi: 10.1016/s0022-3476(05)83284-6. [DOI] [PubMed] [Google Scholar]
- 44.Loftis L. Acute infectious upper airway obstructions in children. Semin Pediatr Infect Dis. 2006;17:5–10. doi: 10.1053/j.spid.2005.11.003. [DOI] [PubMed] [Google Scholar]
- 45.Day H, Lo S, Papsin BC. Retropharyngeal and parapharyngeal infections in children: the Toronto experience. Int J Pediatr Otorhinolaryngol. 2005;69:81–86. doi: 10.1016/j.ijporl.2004.08.010. [DOI] [PubMed] [Google Scholar]
- 46.McEniery J, Gillis JG, Kilham H. Review of intubation in severe laryngotracheobronchitis. Pediatrics. 1991;87:847–853. [PubMed] [Google Scholar]
- 47.Chang AB, Eastburn MM, Gaffney J. Cough quality in children: a comparison of subjective vs. bronchoscopic findings. Respir Res. 2005;6:1–8. doi: 10.1186/1465-9921-6-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Johnson DW. Croup. BMJ Clin Evid. 2014;2014 pii:0321. [PMC free article] [PubMed] [Google Scholar]
- 49.Chang AB, Phelan PD, Sawyer SM. Airway hyperresponsiveness and cough-receptor sensitivity in children with recurrent cough. Am J Respir Crit Care Med. 1997;155:1935–1939. doi: 10.1164/ajrccm.155.6.9196099. [DOI] [PubMed] [Google Scholar]
- 50.Shields MD, Doherty GM. Chronic cough in children. Paediatr Respir Rev. 2013;14:100–106. doi: 10.1016/j.prrv.2012.05.002. [DOI] [PubMed] [Google Scholar]
- 51.Wagner JB, Pine HS. Chronic cough in children. Pediatr Clin North Am. 2013;60:951–967. doi: 10.1016/j.pcl.2013.04.004. [DOI] [PubMed] [Google Scholar]
- 52.Acosta R, Bahna SL. Chronic cough in children. Pediatr Ann. 2014;43:e176–e183. doi: 10.3928/00904481-20140723-07. [DOI] [PubMed] [Google Scholar]
- 53.Kaslovsky R, Sadof M. Chronic cough in children: a primary care and subspecialty collaborative approach. Pediatr Rev. 2013;34:498–508. doi: 10.1542/pir.34-11-498. [DOI] [PubMed] [Google Scholar]
- 54.Goldsobel AB, Chipps BE. Cough in the pediatric population. J Pediatr. 2010;116:352–358. doi: 10.1016/j.jpeds.2009.12.004. [DOI] [PubMed] [Google Scholar]
- 55.Khoshoo V, Edell D, Mohnot S. Associated factors in children with chronic cough. Chest. 2009;136:811–815. doi: 10.1378/chest.09-0649. [DOI] [PubMed] [Google Scholar]
- 56.Asilsoy S, Bayram E, Agin H. Evaluations of chronic cough in children. Chest. 2008;134:1122–1128. doi: 10.1378/chest.08-0885. [DOI] [PubMed] [Google Scholar]
- 57.Schidlow DV. Cough. In: Schidlow DV, Smith DS, editors. A Practical Guide to Pediatric Respiratory Disease. Hanley & Belfus; Philadelphia: 1994. pp. 49–51. [Google Scholar]
- 58.Davis SF, Sutter RW, Strebel PM. Concurrent outbreaks of pertussis and Mycoplasma pneumoniae infection: clinical and epidemiological characteristics of illnesses manifested by cough. Clin Infect Dis. 1995;20:621–628. doi: 10.1093/clinids/20.3.621. [DOI] [PubMed] [Google Scholar]
- 59.Jackson LA, Cherry JD, Wang SP. Frequency of serological evidence of Bordetella infections and mixed infections with other respiratory pathogens in university students with cough illness. Clin Infect Dis. 2000;31:3–6. doi: 10.1086/313911. [DOI] [PubMed] [Google Scholar]
- 60.Donnelly D, Critchow A, Everard ML. Outcomes in children treated for persistent bacterial bronchitis. Thorax. 2007;62:80–84. doi: 10.1136/thx.2006.058933. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Marchant JM, Gibson PG, Grissell TV. Prospective assessment of protracted bacterial bronchitis: airway inflammation and innate immune activation. Pediatr Pulmonol. 2008;43:1092–1099. doi: 10.1002/ppul.20906. [DOI] [PubMed] [Google Scholar]
- 62.Bradley JS, Byington C, Shah SS. The management of community-acquired pneumonia (CAP) in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53:e25–e76. doi: 10.1093/cid/cir531. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.World Health Organization (WHO) WHO; Geneva: 1991. Acute respiratory infections in children: case management in small hospitals in developing countries. WHO ducument WHO/ARI/90.5. [Google Scholar]
- 64.World Health Organization Pneumonia fact sheet N0331. 2015. http://www.who.int/mediacentre/factsheets/fs331/en/
- 65.Dai Y, Foy HM, Zhu Z. Respiratory rate and signs in roentgenographically confirmed pneumonia among children in China. Pediatr Infect Dis J. 1995;14:48–50. doi: 10.1097/00006454-199501000-00010. [DOI] [PubMed] [Google Scholar]
- 66.Singhi S, Dhawan A, Kataria S. Clinical signs of pneumonia in infants under 2 months. Arch Dis Child. 1994;70:413–417. doi: 10.1136/adc.70.5.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Shah S, Bachur R, Kim D. Lack of predictive value of tachypnea in the diagnosis of pneumonia in children. Pediatr Infect Dis J. 2009;29:406–409. doi: 10.1097/INF.0b013e3181cb45a7. [DOI] [PubMed] [Google Scholar]
- 68.Crain EF, Bulas D, Bijur PE. Is a chest radiograph necessary in the evaluation of every febrile infant less than 8 weeks of age? Pediatrics. 1991;88:821–824. [PubMed] [Google Scholar]
- 69.Bramson RT, Meyer TL, Silbiger ML. The futility of the chest radiograph in the febrile infant without respiratory symptoms. Pediatrics. 1993;92:524–526. [PubMed] [Google Scholar]
- 70.Matthews B, Shah S, Cleveland RH. Clinical predictors of pneumonia among children with wheezing. Pediatrics. 2009;124:e29–e36. doi: 10.1542/peds.2008-2062. [DOI] [PubMed] [Google Scholar]
- 71.Homier V, Bellavance C, Xhignesse M. Prevalence of pneumonia in children under 12 years of age who undergo abdominal radiography in the emergency department. CJEM. 2007;9:347–351. doi: 10.1017/s1481803500015293. [DOI] [PubMed] [Google Scholar]
- 72.Poole SR, Chetham M, Anderson M. Grunting respirations in infants and children. Pediatr Emerg Care. 1995;11:158–161. doi: 10.1097/00006565-199506000-00004. [DOI] [PubMed] [Google Scholar]
- 73.Meissner HC. Viral bronchiolitis in children. N Engl J Med. 2016;374:62–72. doi: 10.1056/NEJMra1413456. [DOI] [PubMed] [Google Scholar]
- 74.Murphy CG, van de Pol AC, Harper MB. Clinical predictors of occult pneumonia in the febrile child. Acad Emerg Med. 2007;14:243–249. doi: 10.1197/j.aem.2006.08.022. [DOI] [PubMed] [Google Scholar]
- 75.Rutman MS, Bachur R, Harper MB. Radiographic pneumonia in young, highly febrile children with leukocytosis before and after universal conjugate pneumococcal vaccine. Pediatr Emerg Care. 2009;25:1–7. doi: 10.1097/PEC.0b013e318191dab2. [DOI] [PubMed] [Google Scholar]
- 76.Brasfield DM, Stagno S, Whitley RJ. Infant pneumonitis associated with cytomegalovirus, Chlamydia, Pneumocystis, and Ureaplasma: follow-up. Pediatrics. 1987;79:76–83. [PubMed] [Google Scholar]
- 77.Doan QH, Kissoon N, Dobson K. A randomized, controlled trial of the impact of early and rapid diagnosis of viral infections in children brought to an emergency department with febrile respiratory tract illnesses. J Pediatr. 2009;154:91–95. doi: 10.1016/j.jpeds.2008.07.043. [DOI] [PubMed] [Google Scholar]
- 78.Wubbel L, Muniz L, Ahmed A. Etiology and treatment of community-acquired pneumonia in ambulatory children. Pediatr Infect Dis J. 1999;18:97–98. doi: 10.1097/00006454-199902000-00004. [DOI] [PubMed] [Google Scholar]
- 79.Heiskanen-Kosma T, Korppi M, Jokinen C. Etiology of childhood pneumonia: serologic results of a prospective, population-based study. Pediatr Infect Dis J. 1998;17:986–990. doi: 10.1097/00006454-199811000-00004. [DOI] [PubMed] [Google Scholar]
- 80.Juven T, Mertsola J, Waris M. Etiology of community- acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J. 2000;19:293–296. doi: 10.1097/00006454-200004000-00006. [DOI] [PubMed] [Google Scholar]
- 81.Vuori E, Peltola H, Kallio M. Etiology of pneumonia and other common childhood infections requiring hospitalization and parenteral antimicrobial therapy. Clin Infect Dis. 1998;27:566–572. doi: 10.1086/514697. [DOI] [PubMed] [Google Scholar]
- 82.Shinefield HR, Black S. Efficacy of pneumococcal conjugate vaccines in large scale field trials. Pediatr Infect Dis J. 2000;19:394–397. doi: 10.1097/00006454-200004000-00036. [DOI] [PubMed] [Google Scholar]
- 83.Grijalva CG, Nuorti JP, Arbogast PG. Decline in pneumonia admission after routine childhood immunization with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet. 2007;369:1179–1186. doi: 10.1016/S0140-6736(07)60564-9. [DOI] [PubMed] [Google Scholar]
- 84.Neuman MI, Harper MB. Evaluation of a rapid urine antigen assay for the detection of invasive pneumococcal disease in children. Pediatrics. 2003;112:1279–1282. doi: 10.1542/peds.112.6.1279. [DOI] [PubMed] [Google Scholar]
- 85.Charkaluk ML, Kalach N, Muago H. Assessment of rapid urinary antigen detection by an immunochromatographic-test for diagnosis of pneumococcal infection in children. Diagn Microbiol Infect Dis. 2006;55:89–94. doi: 10.1016/j.diagmicrobio.2005.10.013. [DOI] [PubMed] [Google Scholar]
- 86.Wang K, Gill P, Perera R. Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia. Cochrane Database Syst Rev. 2012;(10) doi: 10.1002/14651858.CD009175.pub2. CD009175. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Thurman KA, Walter ND, Schwartz SB. Comparison of laboratory diagnostic procedures for detection of Mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48:1244–1249. doi: 10.1086/597775. [DOI] [PubMed] [Google Scholar]
- 88.Dowell SF, Peeling RW, Boman J. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada) Clin Infect Dis. 2001;33:492–503. doi: 10.1086/322632. [DOI] [PubMed] [Google Scholar]
- 89.Coss-Bu JA, Sachdeva RC, Bricker JT. Hemoptysis: a 10-year retrospective study. Pediatrics. 1997;100:E7. doi: 10.1542/peds.100.3.e7. [DOI] [PubMed] [Google Scholar]
